copper gluconate has been researched along with Precancerous Conditions in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, V; Connor, L; Corcoran, A; Daum, G; Etemad, B; Fong, LY; Huntington, W; Kossenkov, A; Lander, J; Leroy, K; Mathew, A; Mayilvaganan, B; McDonnell, E; McShane, S; Mercogliano, G; Mullin, JM; Newman, G; Raines, J; Richardson, E; Rybakovsky, E; Thornton, J; Trembeth, S; Urbas, R; Valenzano, MC; Wong, P; Yalamanchili, S; Zitin, M | 1 |
| Abe, M; Furukawa, S; Hayashi, S; Igarashi, M; Nakae, D; Ogawa, I; Usuda, K | 1 |
1 trial(s) available for copper gluconate and Precancerous Conditions
| Article | Year |
|---|---|
Zinc Gluconate Induces Potentially Cancer Chemopreventive Activity in Barrett's Esophagus: A Phase 1 Pilot Study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Barrett Esophagus; Chemoprevention; Esophageal Neoplasms; Female; Gluconates; Humans; Male; MicroRNAs; Middle Aged; Pilot Projects; Precancerous Conditions; Prospective Studies; Sequence Analysis, RNA | 2021 |
1 other study(ies) available for copper gluconate and Precancerous Conditions
| Article | Year |
|---|---|
Carcinogenic risk of copper gluconate evaluated by a rat medium-term liver carcinogenicity bioassay protocol.
Topics: Administration, Oral; Animals; Apoptosis; Biological Assay; Carcinogenicity Tests; Carcinogens; Cell Proliferation; Diet; Dose-Response Relationship, Drug; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gluconates; Glutathione Transferase; Guanine; Hepatectomy; Hepatocytes; Liver; Liver Neoplasms; Male; Metallothionein; Metals; Oxidative Stress; Precancerous Conditions; Rats; Rats, Inbred F344; RNA, Messenger | 2008 |